V

ViewPoint Therapeutics

50 employees

ViewPoint Therapeutics is a developer of crystallin stabilizers intended to prevent and treat cataracts and presbyopia.

Basic info

Industry

research services

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2014

Funding rounds raised

Total raised

$35M

from 6 investors over 6 rounds

V

ViewPoint Therapeutics raised $35M on March 5, 2018

Investors: Mission Bay Capital, Lagunita Biosciences and Mission BioCapital

V

ViewPoint Therapeutics raised $4M on May 5, 2016

Investors: Mission Bay Capital, Asset Management Ventures and Lagunita Biosciences

FAQ